Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric J Small

Showing results (71-80 of 361) with videos related to

Pageof 37
Sort By:
The Journal of Urology|January 16, 2007
The impact of prior radical prostatectomy in men with metastatic castration recurrent prostate cancer: a pooled analysis of 9 Cancer and Leukemia Group B TrialsSusan Halabi, Nicholas J Vogelzang, San-San Ou, et al.
Seminars in Urologic Oncology|August 29, 2002
Neoadjuvant strategies for prostate cancer prior to radical prostatectomyMaxwell V Meng, Gary D Grossfeld, Peter R Carroll, et al.
Clinical Genitourinary Cancer|January 26, 2020
Relationship Between Metastasis-free Survival and Overall Survival in Patients With Nonmetastatic Castration-resistant Prostate CancerMatthew R Smith, Maneesha Mehra, Sandhya Nair, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2005
Prostate cancer immunology: biology, therapeutics, and challengesW Scott Webster, Eric J Small, Brian I Rini, et al.
Urology|January 30, 2004
Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized diseaseJames A Eastham, William K Kelly, Gary D Grossfeld, et al.
Cancer|December 19, 2013
Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic renal cell carcinomaSusan Halabi, Brian Rini, Bernard Escudier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2013
Evaluation of treatment benefit in Journal of Clinical OncologyPamela J Goodwin, Karla V Ballman, Eric J Small, et al.
The Journal of Urology|May 16, 2006
Clinical and immunological characteristics of patients with serologic progression of prostate cancer achieving long-term disease control with granulocyte-macrophage colony-stimulating factorBrian I Rini, Lawrence Fong, Vivian Weinberg, et al.
Clinical Nuclear Medicine|March 5, 2019
Incidentally Detected Oropharyngeal Squamous Cell Carcinoma on 18F-Fluciclovine PET/CTKesav Raghavan, Kwun Wah Wen, Eric J Small, et al.
Cancer|February 14, 2015
Progression-free survival: does a correlation with survival justify its role as a surrogate clinical endpoint?Susan Halabi, Brian I Rini, Bernard Escudier, et al.
Pageof 37

Showing results (71-80 of 361) with videos related to

Sort By:
Pageof 37
The Journal of Urology|January 16, 2007
The impact of prior radical prostatectomy in men with metastatic castration recurrent prostate cancer: a pooled analysis of 9 Cancer and Leukemia Group B TrialsSusan Halabi, Nicholas J Vogelzang, San-San Ou, et al.
Seminars in Urologic Oncology|August 29, 2002
Neoadjuvant strategies for prostate cancer prior to radical prostatectomyMaxwell V Meng, Gary D Grossfeld, Peter R Carroll, et al.
Clinical Genitourinary Cancer|January 26, 2020
Relationship Between Metastasis-free Survival and Overall Survival in Patients With Nonmetastatic Castration-resistant Prostate CancerMatthew R Smith, Maneesha Mehra, Sandhya Nair, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2005
Prostate cancer immunology: biology, therapeutics, and challengesW Scott Webster, Eric J Small, Brian I Rini, et al.
Urology|January 30, 2004
Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized diseaseJames A Eastham, William K Kelly, Gary D Grossfeld, et al.
Cancer|December 19, 2013
Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic renal cell carcinomaSusan Halabi, Brian Rini, Bernard Escudier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2013
Evaluation of treatment benefit in Journal of Clinical OncologyPamela J Goodwin, Karla V Ballman, Eric J Small, et al.
The Journal of Urology|May 16, 2006
Clinical and immunological characteristics of patients with serologic progression of prostate cancer achieving long-term disease control with granulocyte-macrophage colony-stimulating factorBrian I Rini, Lawrence Fong, Vivian Weinberg, et al.
Clinical Nuclear Medicine|March 5, 2019
Incidentally Detected Oropharyngeal Squamous Cell Carcinoma on 18F-Fluciclovine PET/CTKesav Raghavan, Kwun Wah Wen, Eric J Small, et al.
Cancer|February 14, 2015
Progression-free survival: does a correlation with survival justify its role as a surrogate clinical endpoint?Susan Halabi, Brian I Rini, Bernard Escudier, et al.
Pageof 37